Expression and Localization of AβPP in SH-SY5Y Cells Depends on Differentiation State

J Alzheimers Dis. 2021;82(2):485-491. doi: 10.3233/JAD-201409.

Abstract

Neuroblastoma cell line SH-SY5Y, due to its capacity to differentiate into neurons, easy handling, and low cost, is a common experimental model to study molecular events leading to Alzheimer's disease (AD). However, it is prevalently used in its undifferentiated state, which does not resemble neurons affected by the disease. Here, we show that the expression and localization of amyloid-β protein precursor (AβPP), one of the key molecules involved in AD pathogenesis, is dramatically altered in SH-SY5Y cells fully differentiated by combined treatment with retinoic acid and BDNF. We show that insufficient differentiation of SH-SY5Y cells results in AβPP mislocalization.

Keywords: Alzheimer’s disease; AβPP; SH-SY5Y; differentiation; super-resolution microscopy.

Publication types

  • Letter

MeSH terms

  • Alzheimer Disease / metabolism*
  • Amyloid beta-Protein Precursor / metabolism*
  • Brain-Derived Neurotrophic Factor* / metabolism
  • Brain-Derived Neurotrophic Factor* / pharmacology
  • Cell Differentiation / physiology*
  • Cell Line, Tumor
  • Humans
  • Intravital Microscopy / methods
  • Models, Biological
  • Neuroblastoma
  • Neurons / physiology*
  • Oxidative Stress
  • Proteolysis
  • Tretinoin* / metabolism
  • Tretinoin* / pharmacology

Substances

  • Amyloid beta-Protein Precursor
  • Brain-Derived Neurotrophic Factor
  • Tretinoin